Calcitonin-induced change in serum calcium levels and its relationship to osteoclast morphology and number of calcitonin receptors

Bone

Volumn 35, Issue 1, 2004, Pages 27-33

  Ikegame, Mika ^a   Ejiri, Sadakazu ^b   Ozawa, Hidehiro ^c  

^a OKAYAMA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c MATSUMOTO DENTAL UNIVERSITY   (Japan)

Author keywords

Calcitonin; Osteoclast morphology; Serum calcium levels

Indexed keywords

CALCITONIN RECEPTOR; CALCIUM; ELCATONIN; IODINE 125;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM BINDING; CALCIUM BLOOD LEVEL; CALCIUM BONE LEVEL; CELL ULTRASTRUCTURE; CONTROLLED STUDY; EVALUATION; HORMONE RECEPTOR INTERACTION; INCUBATION TIME; NONHUMAN; OSTEOCLAST; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY; SKULL; WHOLE BODY AUTORADIOGRAPHY;

ANIMALS; AUTORADIOGRAPHY; CALCITONIN; CALCIUM; DOWN-REGULATION; MICROSCOPY, ELECTRON, TRANSMISSION; OSTEOCLASTS; PARIETAL BONE; RATS; RATS, WISTAR; RECEPTORS, CALCITONIN;

EID: 2942726359     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2004.03.018     Document Type: Article

References (36)

1. Copp D.H., Cameron E.C., Cheney B.A., Davidson A.G.F., Henze K.G. Evidence for calcitonin - A new hormone from the parathyroid that lowers blood calcium. Endocrinology. 70:1962;638-649
2. Hirsch P.F., Gauthier G.F., Munson P.L. Thyroid hypocalcemic principle and recurrent laryngeal nerve injury as factors affecting the response to parathyroidectomy in rats. Endocrinology. 73:1963;244-252
3. Hirsch P.F., Voelkel E.F., Munson P.L. Thyrocalcitonin: hypocalcemic hypophosphatemic principle of the thyroid gland. Science. 146:1964;412-413
4. Aliapoulios M.A., Goldhaber P., Munson P.L. Thyrocalcitonin inhibition of bone resorption induced by parathyroid hormone in tissue culture. Science. 151:1966;330-331
5. Raisz L.G., Niemann I. Early effects of parathyroid hormone and thyrocalcitonin on bone in organ culture. Nature. 214:1967;486-487
6. Warshawsky H., Goltzman D., Rouleau M.F., Bergeron J.J. Direct in vivo demonstration by radioautography of specific binding sites for calcitonin in skeletal and renal tissues of the rat. J. Cell Biol. 85:1980;682-694
7. Nicholson G.C., Moseley J.M., Sexton P.M., Mendelsohn F.A., Martin T.J. Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J. Clin. Invest. 78:1986;355-360
8. Chambers T.J., Magnus C.J. Calcitonin alters behaviour of isolated osteoclasts. J. Pathol. 136:1982;27-39
9. Gay C.V. Osteoclast ultrastructure and enzyme histochemistry: functional implications. Rifkin B.R., Gay C.V. Biology and physiology of the osteoclast. 1992;129-150 CRC Press, Florida, USA
10. Zichner L. The effect of calcitonin on bone cells in young rats. An electron microscopic study. Isr. J. Med. Sci. 7:1971;359-366
11. Kallio D.M., Garant P.R., Minkin C. Ultrastructural effects of calcitonin on osteoclasts in tissue culture. J. Ultrastruct. Res. 39:1972;205-216
12. Lucht U. Effects of calcitonin on osteoclasts in vivo. An ultrastructural and histochemical study. Z. Zellforsch. Mikrosk. Anat. 145:1973;75-87
13. Raisz L.G., Au W.Y.W., Friedman J., Niemann I. Thyrocalcitonin and bone resorption. Am. J. Med. 43:1967;684-690
14. Friedman J., Au W.Y.W., Raisz L.G. Responses of fetal rat bone to thyrocalcitonin in tissue culture. Endocrinology. 82:1968;149-156
15. Wener J.A., Gorton S.J., Raisz L.G. Escape from inhibition or resorption in cultures of fetal bone treated with calcitonin and parathyroid hormone. Endocrinology. 90:1972;752-759
16. Chambers T.J. Osteoblasts release osteoclasts from calcitonin-induced quiescence. J. Cell Sci. 57:1982;247-260
17. Kanehisa J. Time course of "escape" from calcitonin-induced inhibition of motility and resorption of disaggregated osteoclasts. Bone. 10:1989;125-129
18. Messer H.H., Copp D.H. Changes in response to calcitonin following prolonged administration to intact rats. Proc. Soc. Exp. Biol. Med. 146:1974;643-647
19. Au W.Y. Calcitonin treatment of hypercalcemia due to parathyroid carcinoma. Synergistic effect of prednisone on long-term treatment of hypercalcemia. Arch. Intern. Med. 135:1975;1594-1597
20. Singer F.R., Fredericks R.S., Minkin C. Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance. Arthritis Rheum. 23:1980;1148-1154
21. Delmas P.D., Meunier P.J. The management of Paget's disease of bone. N. Engl. J. Med. 336:1997;558-566
22. Tashjian A.H. Jr., Wright D.R., Ivey J.L., Pont A. Calcitonin binding sites in bone: relationships to biological response and "escape" Recent Prog. Horm. Res. 34:1978;285-334
23. Wada S., Martin T.J., Findlay D.M. Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells. Endocrinology. 136:1995;2611-2621
24. Findlay D.M., Martin T.J. Relationship between internalization and calcitonin-induced receptor loss in T 47D cells. Endocrinology. 115:1984;78-83
25. Findlay D.M., Martin T.J. Kinetics of calcitonin receptor internalization in lung cancer (BEN) and osteogenic sarcoma (UMR 106-06) cells. J. Bone Miner. Res. 1:1986;277-283
26. Schneider H.G., Raue F., Zink A., Koppold A., Ziegler R. Down-regulation of calcitonin receptors in T47D cells by internalization of calcitonin-receptor complexes. Mol. Cell. Endocrinol. 58:1988;9-15
27. Ikegame M., Ejiri S., Ozawa H. Histochemical and autoradiographic studies on elcatonin internalization and intracellular movement in osteoclasts. J. Bone Miner. Res. 9:1994;25-37
28. Rakopoulos M., Ikegame M., Findlay D.M., Martin T.J., Moseley J.M. Short treatment of osteoclasts in bone marrow culture with calcitonin causes prolonged suppression of calcitonin receptor mRNA. Bone. 17:1995;447-453
29. Takahashi S., Goldring S., Katz M., Hilsenbeck S., Williams R., Roodman G.D. Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation. J. Clin. Invest. 95:1995;167-171
30. Inoue D., Shih C., Galson D.L., Goldring S.R., Horne W.C., Baron R. Calcitonin-dependent down-regulation of the mouse C1a calcitonin receptor in cells of the osteoclast lineage involves a transcriptional mechanism. Endocrinology. 140:1999;1060-1068
31. Ikegame M., Rakopoulos M., Martin T.J., Moseley J.M., Findlay D.M. Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures. J. Bone Miner. Res. 11:1996;456-465
32. Wada S., Udagawa N., Nagata N., Martin T.J., Findlay D.M. Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts. Endocrinology. 137:1996;1042-1048
33. Gitelman H.J. An improved automated procedure for the determination of calcium in biological specimens. Anal. Biochem. 18:1967;521-531
34. Cole A.A., Walters L.M. Tartrate-resistant acid phosphatase in bone and cartilage following decalcification and cold-embedding in plastic. J. Histochem. Cytochem. 35:1987;203-206
35. Holtrop M.E., Raisz L.G., Simmons H.A. The effects of parathyroid hormone, colchicine, and calcitonin on the ultrastructure and the activity of osteoclasts in organ culture. J. Cell Biol. 60:1974;346-355
36. Wada S., Udagawa N., Nagata N., Martin T.J., Findlay D.M. Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase Alpha-mediated mechanism. Endocrinology. 137:1996;312-320